Network pharmacology and RNA-seq revealed that CE suppresses cholesterol synthesis in SCLC cells by downregulating key rate-limiting enzymes (HMGCS1, HMGCR, IDI1, FDFT1, and SQLE). This evidence concerns the gene HMGCS1 and small cell lung carcinoma.